Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about ABBV
Recent news which mentions ABBV
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
32
33
Next >
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
October 03, 2024
Tickers
ABBV
GSK
NEWS
NVO
Tags
Health Care
Market News
Stories That Matter
From
Benzinga
5 Best Dividend Growth Stocks to Buy in October
October 02, 2024
Tickers
ABBV
AXP
BAC
COST
Tags
BAC
AXP
ABBV
From
Motley Fool
Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
September 30, 2024
Tickers
ABBV
ACN
DIS
META
Tags
Media
Market News
Brenda Vingiello
From
Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
September 27, 2024
Tickers
ABBV
Tags
Short Ideas
Trading Ideas
Short Sellers
From
Benzinga
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
Tickers
ABBV
BMY
NEWS
Tags
News
Top Stories
General
From
Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
September 26, 2024
Tickers
ABBV
NEWS
Tags
BZI/POD
Trading Ideas
News
From
Benzinga
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
September 26, 2024
Tickers
ABBV
NEWS
Tags
Briefs
ABBV
Top Stories
From
Benzinga
Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
September 26, 2024
Tickers
ABBV
NVO
Tags
ABBV
Recent Press Releases
NVO
From
Motley Fool
Behind the Scenes of AbbVie's Latest Options Trends
September 24, 2024
Tickers
ABBV
Tags
Markets
Benzinga
BZI/UOA
From
Benzinga
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
September 20, 2024
Tickers
ABBV
BMY
NEWS
Tags
Biotech
Benzinga
Stories That Matter
From
Benzinga
Spotlight on AbbVie: Analyzing the Surge in Options Activity
September 20, 2024
Tickers
ABBV
Tags
Markets
Benzinga
BZI/UOA
From
Benzinga
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
September 19, 2024
Tickers
ABBV
NEWS
Tags
News
ABBV
Market News
From
Benzinga
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
September 19, 2024
Tickers
ABBV
AZN
Tags
AZN
Recent Press Releases
ABBV
From
Motley Fool
TransDigm, BJ's Wholesale, AbbVie And More On CNBC's 'Final Trades'
September 17, 2024
Tickers
ABBV
BJ
NEWS
SMH
Tags
Media
Market News
Anastasia Amoroso
From
Benzinga
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
September 16, 2024
Tickers
ABBV
ABT
Tags
Recent Press Releases
ABBV
Market News
From
Motley Fool
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
September 14, 2024
Tickers
ABBV
MRNA
Tags
ABBV
Recent Press Releases
Market News
From
Motley Fool
3 Stocks to Buy and Hold Forever
September 14, 2024
Tickers
ABBV
ABT
LLY
VRTX
Tags
Recent Press Releases
ABBV
Market News
From
Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
September 14, 2024
Tickers
ABBV
BIP
BIPC
VZ
Tags
BIP
BIPC
VZ
From
Motley Fool
Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
September 13, 2024
Tickers
ABBV
Tags
Market News
Recent Press Releases
ABBV
From
Motley Fool
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
September 11, 2024
Tickers
ABBV
ALVO
AMGN
CI
Tags
Briefs
SDZNY
News
From
Benzinga
What the Options Market Tells Us About AbbVie
September 11, 2024
Tickers
ABBV
Tags
BZI/UOA
ABBV
Market News
From
Benzinga
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
September 10, 2024
Tickers
ABBV
CAH
CVS
NEWS
Tags
Legal
Briefs
Pharamceuticals
From
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.